TileBio is an AI-driven biotech startup focused on pathology foundation models.
TileBio has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
TileBio's investors include GU Holdings, Scottish Enterprise, Twin Path Ventures.
TileBio is headquartered in Glasgow, United Kingdom.
TileBio is an AI-driven biotech startup focused on pathology foundation models.
TileBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TileBio — Funding & Investors." VCBacked, February 16, 2026, https://www.vcbacked.co/company/tilebio. Accessed September 29, 2026.
VCBacked. (2026). TileBio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/tilebio
{{cite web |title=TileBio — Funding & Investors |url=https://www.vcbacked.co/company/tilebio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated